Could gold mining and herbal remedies be damaging nerves? new study investigates

NCT ID NCT07341997

Recruiting now Knowledge-focused Sponsor: Admin CIC Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether environmental factors like heavy metals from gold mining, past viral infections, or traditional plant remedies are linked to peripheral neuropathy (nerve damage) in French Guiana. Researchers will compare 78 people with and without nerve damage to see if exposure rates differ. The goal is to better understand why some cases of neuropathy have no clear cause.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could identify environmental triggers for unexplained nerve damage, pointing toward prevention strategies in affected regions.
What could go wrong: This is an observational study with a small sample size (78 participants). It cannot prove cause and effect, only associations, and results may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BITA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic idiopathic neuropathy diabetic neuropathy lead poisoning mercury poisoning peripheral nervous system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BITA ENVIRONMENTAL RISK FACTOR LEAD NEUROPATHY MERCURY NEUROPATHY PERIPHERAL NEUROPATHIES

Contacts and locations

Locations

Centre Hospitalier de Cayenne
RECRUITING

Cayenne, 97300, French Guiana
Centre Hospitalier de l'Ouest Guyanais
RECRUITING

Saint-Laurent-du-Maroni, 97320, French Guiana

More trials for these conditions

Other studies related to the condition(s) this trial covers.